Bladder cancer diagnosis and identification of clinically significant disease by combined urinary detection of Mcm5 and nuclear matrix protein 22.
Kelly, John D
Bladder cancer diagnosis and identification of clinically significant disease by combined urinary detection of Mcm5 and nuclear matrix protein 22. [electronic resource] - PloS one 2012 - e40305 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1932-6203
10.1371/journal.pone.0040305 doi
Aged
Area Under Curve
Biomarkers, Tumor--urine
Carcinoma
Carcinoma, Transitional Cell--diagnosis
Cell Cycle Proteins--urine
False Positive Reactions
Female
Humans
Limit of Detection
Male
Middle Aged
Nuclear Proteins--urine
ROC Curve
Statistics, Nonparametric
Urinary Bladder Neoplasms--diagnosis
Bladder cancer diagnosis and identification of clinically significant disease by combined urinary detection of Mcm5 and nuclear matrix protein 22. [electronic resource] - PloS one 2012 - e40305 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1932-6203
10.1371/journal.pone.0040305 doi
Aged
Area Under Curve
Biomarkers, Tumor--urine
Carcinoma
Carcinoma, Transitional Cell--diagnosis
Cell Cycle Proteins--urine
False Positive Reactions
Female
Humans
Limit of Detection
Male
Middle Aged
Nuclear Proteins--urine
ROC Curve
Statistics, Nonparametric
Urinary Bladder Neoplasms--diagnosis